Catheter-Related Focal FDG Activity on Whole Body PET Imaging

Introduction: Whole body FDG positron emission tomography (PET) scan is increasingly being used in the management of a variety of cancers and infections. Cancer patients and other very sick patients have central venous catheters, which could be associated with common complications like thrombosis and infections. We describe catheter-related focal FDG uptake on whole body FDG PET scans in 4 patients. Materials and Methods: Four patients underwent whole body FDG-PET scanning 60 minutes after intravenous injection of F18-FDG (2 for localization of site of infection, 1 for primary cancer site localization, and 1 for restaging of colon cancer). The whole body PET images were compared and correlated with the patients’ history, radiology and laboratory tests. Results: Focal and intense FDG activity is seen in all 4 patients at the distal end of the intravenous catheter. The average SUV of this activity was 6.3 (n = 3). Catheter-related thrombosis was identified as the cause of FDG activity in 3 patients, whereas catheter-related infection was considered in one patient. Conclusion: Focal and intense FDG activity, in relation to the distal end of a central venous catheter, has a benign etiology, usually seen with catheter-related venous thrombosis and can be seen with catheter related infection.

[1]  D. Kuter.  Thrombotic complications of central venous catheters in cancer patients. , 2004, The oncologist.

[2]  A. Valleron,et al.  [Complications due to peripheral venous catheterization. Prospective study]. , 2003, Presse medicale.

[3]  M. Fulham,et al.  FDG positron emission tomographic imaging of a large abdominal aortic aneurysm. , 2003, Clinical nuclear medicine.

[4]  S. Goldhaber,et al.  Upper-extremity deep vein thrombosis. , 2002, Circulation.

[5]  K. Sepkowitz,et al.  Complication rates among cancer patients with peripherally inserted central catheters. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Raman,et al.  F-18 FDG positron emission tomographic image of an aortic aneurysmal thrombus. , 2002, Clinical nuclear medicine.

[7]  Abass Alavi,et al.  Whole-body FDG-PET imaging in the management of patients with cancer. , 2002, Seminars in nuclear medicine.

[8]  Abass Alavi,et al.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. , 2002, Seminars in nuclear medicine.

[9]  M. Monreal,et al.  Thrombotic Complications of Central Venous Catheters in Cancer Patients , 2001, Acta Haematologica.

[10]  R. Quaife,et al.  FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging. , 2001, Clinical nuclear medicine.

[11]  M D Blaufox,et al.  PET imaging in oncology. , 2000, Seminars in nuclear medicine.

[12]  I. Raad,et al.  Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections , 1999, Supportive Care in Cancer.

[13]  A. Sitges-Serra.  Strategies for prevention of catheter-related bloodstream infections , 1999, Supportive Care in Cancer.

[14]  Maisey,et al.  F-18 fluorodeoxyglucose PET in the diagnosis of vascular invasion in renal cell carcinoma , 1999, Clinical nuclear medicine.

[15]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[16]  R. V. Van Heertum,et al.  Differentiation of cardiac tumor from thrombus by combined MRI and F-18 FDG PET imaging. , 1998, Clinical nuclear medicine.

[17]  F. Dehdashti,et al.  Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. , 1997, AJR. American journal of roentgenology.

[18]  I. Fogelman,et al.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. , 1996, Seminars in nuclear medicine.

[19]  A. Buck,et al.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  T Ido,et al.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.